Skip to the answer

Terbinafine

Terbinafine is an allylamine antifungal used to treat fungal infections of the nails (as tablets) and of the skin, such as athlete’s foot, jock itch and ringworm (as topical products).

Brand names LamisilSilka CreamAthletes FootLamisil AT CreamGood Neighbor Pharmacy +11 more
Drug class Allylamine Antifungal
Rx/OTC Forms 4
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026 Content updated Oct 2, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 48 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

✓No current FDA shortage listed · checked Oct 7, 2026
Terbinafine at a glance The quick version — the full detail is in the Patient Information Guide below.
Dr. Brian Staiger, PharmD, BCPS
The Pharmacist’s Take By · Clinical pharmacist · Written

Terbinafine is an antifungal that blocks an enzyme fungi need for their cell membranes, used as tablets for nail fungus and as creams and sprays for athlete's foot, jock itch and ringworm; on the market since about 1992 and available as a generic, the tablets are a usual first choice. Most people tolerate it well, with headache and an upset stomach the usual complaints, but report any change in taste or smell, which can be permanent. The tablets' serious risk is liver failure, even in people with healthy livers, so expect blood tests before and during treatment and call promptly for dark urine or yellowing skin or eyes.

Clinical pearls

  • Nails grow slowly, so toenails can still look abnormal after the course ends; clear new growth from the base is the good sign.
  • Terbinafine can raise levels of many antidepressants, beta-blockers and flecainide, and with desipramine the effect lasted weeks after stopping.
  • If you take warfarin, ask about extra INR (clotting blood test) checks, since clotting times have changed with terbinafine tablets.
  • Keep applying the cream or spray for the full time on the label, even after the itching stops.
How you get itPrescription and over the counter
Comes asTablet, Topical cream, ointment or gel, Topical spray +1
Earliest FDA record1992
Companies listing it with the FDA41
FDA label last updatedOct 29, 2020
FDA’s strongest warning (boxed)None on the label

Patient information guide A plain-language walkthrough of Terbinafine, written from its FDA label.

What Terbinafine is used for

▾

Terbinafine is used for fungal infections, and the use depends on the product.

  • Terbinafine tablets (oral): fungal infection of the toenail or fingernail due to dermatophytes (onychomycosis).
  • Lamisil AT spray and creams (topical): most athlete’s foot, jock itch and ringworm, plus itching, burning, cracking and scaling.
  • CVS cream: jock itch.
  • Toenail Fungus Treatment (topical liquid): nail fungus, discoloration, thickening, splitting, crumbling and brittleness.

For Lamisil AT spray, effectiveness on the bottom or sides of the foot is unknown.

How Terbinafine works

▾

Terbinafine is an allylamine antifungal. It blocks squalene epoxidase, an enzyme fungi use to build ergosterol, which is an essential part of their cell membrane.

Blocking this enzyme lets squalene build up inside the fungus. This makes the membrane leaky and leads to fungal cell death.

Terbinafine dosage

▾

Terbinafine tablets are taken by mouth once daily, with or without food. Fingernail infections are treated for about 6 weeks and toenail infections for about 12 weeks. Your nail may take months after treatment ends to look healthy, because the healthy nail has to grow out.

  • Topical creams and sprays go on clean, dry skin.
  • Athlete’s foot is generally treated twice a day. Jock itch and ringworm are generally treated once a day.
  • Treatment usually lasts 1 to 2 weeks, depending on the area treated.
  • Wash your hands after each use.

Follow your prescriber’s directions and the product label.

Dosing details from the FDA-approved label

From the Terbinafine prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.

  • Fingernail onychomycosis (oral tablet)
    • One 250 mg tablet once daily for 6 weeks
    • Evaluate patients for evidence of chronic or active liver disease before administering
  • Toenail onychomycosis (oral tablet)
    • One 250 mg tablet once daily for 12 weeks
    • Evaluate patients for evidence of chronic or active liver disease before administering
  • Athlete's foot between the toes, adults and children 12 years and older (topical cream)
    • Apply twice a day (morning and night) for 1 week or as directed by a doctor
    • Wear well-fitting, ventilated shoes; change shoes and socks at least once daily
  • Athlete's foot on the bottom or sides of the foot, adults and children 12 years and older (topical cream)
    • Apply twice a day (morning and night) for 2 weeks or as directed by a doctor
    • Wear well-fitting, ventilated shoes; change shoes and socks at least once daily
  • Jock itch and ringworm, adults and children 12 years and older (topical cream)
    • Apply once a day (morning or night) for 1 week or as directed by a doctor
  • Athlete's foot between the toes, adults and children 12 years and over (topical spray)
    • Spray twice a day (morning and night) for 1 week or as directed by a doctor
    • Hold can 4" to 6" from skin; wear well-fitting, ventilated shoes
  • Jock itch and ringworm, adults and children 12 years and over (topical spray)
    • Spray affected area once a day (morning or night) for 1 week or as directed by a doctor
  • Children under 12 years (topical products)
    • Ask a doctor
Read the label’s full dosing text

2. DOSAGE AND ADMINISTRATION • Prior to administering, evaluate patients for evidence of chronic or active liver disease. ( 2.1 ) • Fingernail onychomycosis: One 250 mg tablet, once daily for 6 weeks. ( 2.2 ) • Toenail onychomycosis: One 250 mg tablet, once daily for 12 weeks. ( 2.2 ) 2.1 Assessment Prior to Initiation Before administering Terbinafine tablets, evaluate patients for evidence of chronic or active liver disease [see Contraindications (4) and Warnings and Precautions (5.1) ] . 2.2 Dosage Fingernail onychomycosis: One 250 mg tablet once daily for 6 weeks. Toenail onychomycosis: One 250 mg tablet once daily for 12 weeks. The optimal clinical effect is seen some months after mycological cure and cessation of treatment. This is related to the period required for outgrowth of healthy nail.

Read the full Dosage and Administration section on DailyMed →

Terbinafine side effects

▾

Most side effects of the tablets are mild and short-lived. Common ones include:

Common side effects

  • Headache
  • Diarrhea
  • Rash
  • Indigestion (dyspepsia)
  • Itching
  • Nausea
  • Stomach pain
  • Taste changes
  • Gas
  • Liver test changes

When to get medical help

  • Call your doctor right away if you have ongoing nausea, poor appetite, unusual tiredness, vomiting, pain in the upper right belly, yellow skin or eyes, dark urine or pale stools. These can be signs of liver problems.
  • Tell your doctor if you notice a change in or loss of taste or smell. It can be long-lasting or permanent.
  • Report new low mood or depressive symptoms.
  • Get medical help for a spreading or worsening skin rash, blistering or peeling skin, or fever with rash. These can be serious skin reactions.
  • Seek urgent help for signs of a severe allergic reaction, such as swelling of the face or throat or trouble breathing.
  • Tell your doctor about signs of infection, such as fever or sore throat, since severe low white blood cell counts (neutropenia) have been reported.
  • Tell your doctor if a lupus-like illness or a flare of existing lupus develops.

Terbinafine warnings and precautions

▾
  • Liver failure: it has occurred with terbinafine tablets, sometimes leading to transplant or death. Watch for ongoing nausea, tiredness, vomiting, right upper belly pain, jaundice, dark urine or pale stools.
  • Taste or smell loss: it can be severe and may last more than a year or be permanent.
  • Depressive symptoms: report any to your doctor.
  • Low white blood cells: severe neutropenia has been reported.
  • Serious skin reactions: these include Stevens-Johnson syndrome and DRESS.
  • Lupus: terbinafine can trigger or worsen lupus erythematosus.
  • Blood clotting disorders: thrombotic microangiopathy has been reported, some cases fatal.

Terbinafine interactions

▾

Terbinafine tablets can change levels of other medicines, and some medicines change terbinafine levels.

  • CYP2D6-processed drugs (tricyclic antidepressants, SSRIs, beta-blockers, flecainide, propafenone, MAO-B inhibitors): terbinafine blocks their breakdown, so doses may need lowering.
  • Desipramine: levels rose about 5-fold and stayed high for weeks.
  • Fluconazole, ketoconazole, amiodarone: may raise terbinafine levels.
  • Cimetidine: raises terbinafine levels.
  • Rifampin: speeds terbinafine clearance, lowering levels.
  • Warfarin: clotting time changes have been reported.
  • Caffeine: clearance is slightly reduced.

Interactions listed in the FDA-approved label

From the Terbinafine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Drugs metabolized by CYP450 2D6 (tricyclic antidepressants, SSRIs, beta-blockers, class 1C antiarrhythmics e.g. flecainide and propafenone, MAO inhibitors Type B): Terbinafine is an inhibitor of the CYP450 2D6 isozyme and may convert extensive CYP2D6 metabolizers to poor metabolizer status. Coadministration should be done with careful monitoring and may require a reduction in dose of the 2D6-metabolized drug.
  • Desipramine: Terbinafine resulted in a 2-fold increase in Cmax and a 5-fold increase in AUC of desipramine, persisting at 4 weeks after discontinuation.
  • Dextromethorphan: Terbinafine increases the dextromethorphan/dextrorphan metabolite ratio in urine by 16- to 97-fold on average.
  • Caffeine: Terbinafine decreases the clearance of caffeine by 19%.
  • Cyclosporine: Terbinafine increases the clearance of cyclosporine by 15%; terbinafine clearance is unaffected by cyclosporine.
  • Fluconazole: A single 100 mg dose of fluconazole with terbinafine increased terbinafine Cmax by 52% and AUC by 69%.
  • Other inhibitors of both CYP2C9 and CYP3A4 (e.g., ketoconazole, amiodarone): May also lead to a substantial increase in the systemic exposure (Cmax and AUC) of terbinafine.
  • Warfarin: Spontaneous reports of increase or decrease in prothrombin times with oral terbinafine; a causal relationship has not been established.
  • Rifampin: Terbinafine clearance is increased 100% by rifampin, a CYP450 enzyme inducer.
  • Cimetidine: Terbinafine clearance is decreased 33% by cimetidine, a CYP450 enzyme inhibitor.
Read the label’s full interactions text

7. DRUG INTERACTIONS Terbinafine is an inhibitor of CYP450 2D6 isozyme and has an effect on metabolism of desipramine. Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. ( 7.1 ) 7.1 Drug-Drug Interactions In vivo studies have shown that terbinafine is an inhibitor of the CYP450 2D6 isozyme. Drugs predominantly metabolized by the CYP450 2D6 isozyme include the following drug classes: tricyclic antidepressants, selective serotonin reuptake inhibitors, beta-blockers, antiarrhythmics class 1C (e.g., flecainide and propafenone) and monoamine oxidase inhibitors Type B. Coadministration of Terbinafine tablets should be done with careful monitoring and may require a reduction in dose of the 2D6-metabolized drug. In a study to assess the effects of terbinafine on desipramine in healthy volunteers characterized as normal metabolizers, the administration of terbinafine resulted in a 2-fold increase in C max and a 5-fold increase in area under the curve (AUC). In this study, these effects were shown to persist at the last observation at 4 weeks after discontinuation of Terbinafine tablets. In studies in healthy subjects characterized as extensive metabolizers of dextromethorphan (antitussive drug and CYP2D6 probe substrate), terbinafine increases the dextromethorphan/ dextrorphan metabolite ratio in urine by 16- to 97-fold on average. Thus, terbinafine may convert extensive CYP2D6 metabolizers to poor metabolizer status. In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, ethinylestradiol, ethoxycoumarin, cyclosporine, cisapride and fluvastatin. In vivo drug-drug interaction studies conducted in healthy volunteer subjects showed that terbinafine does not affect the clearance of antipyrine or digoxin. Terbinafine decreases the clearance of caffeine by 19%. Terbinafine increases the clearance of cyclosporine by 15%.

Excerpted — the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before taking Terbinafine

▾
  • Do not use the tablets with chronic or active liver disease or a past allergic reaction to oral terbinafine.
  • Liver tests are done before and during treatment.
  • Tell your doctor if you have a weakened immune system or kidney problems.
  • Pregnancy: human data are insufficient to judge risk.
  • Breastfeeding: terbinafine passes into breast milk.
  • Children: the tablets have not been established as safe and effective for nail infection. Ask a doctor before using topical products under age 12.
  • Older adults: dosing should be cautious because of reduced organ function.

Terbinafine overdose

▾

Experience with overdose is limited. Doses up to 5 grams, about 20 times the daily dose, were taken without serious reactions. Symptoms included nausea, vomiting, stomach pain, dizziness, rash, frequent urination and headache.

How your body processes Terbinafine

▾

Terbinafine tablets are well absorbed, though first-pass metabolism leaves about 40% available. Levels peak within about 2 hours, and food changes absorption only slightly. The drug is heavily protein-bound and spreads to the skin and oil glands. It lingers in skin and fat, with a terminal half-life of 200 to 400 hours.

The liver breaks it down with several CYP enzymes, and about 70% leaves in the urine. Clearance drops by about half in kidney impairment or liver cirrhosis.

How to store Terbinafine

▾

Store Terbinafine Tablets, USP at 20° - 25°C (68° - 77°F) .

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →

72

Supplements & herbs that interact with Terbinafine

72 supplements and herbal products have documented interactions with Terbinafine in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.

Severity mix
  • Major · 4
  • Moderate · 45
  • Minor · 23
Every supplement checked against Terbinafine — ranked by severity The full interaction hub: 4 major · 45 moderate · 23 minor · every one linked to its full report. Check Terbinafine against your exact supplements

Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Terbinafine: pharmacist answers to common questions

Quick, plain-English answers to the questions patients ask most about Terbinafine — the kind of thing our pharmacy team would talk through with you at the counter.

What is terbinafine used for?

▾
It depends on the form. The tablets treat fungal infections of the toenails or fingernails. Topical products like Lamisil AT treat athlete’s foot, jock itch and ringworm. Your doctor will usually confirm a nail infection with a lab test first.

How do I take the tablets?

▾
You take one tablet by mouth once a day, with or without food. Fingernails take a shorter course than toenails. Your nail can look better only after healthy nail grows out, which takes months, so don’t be discouraged if it looks the same at first.

Why do I need liver blood tests?

▾
Liver failure has happened with terbinafine tablets, even in people with no liver problems. A blood test before and during treatment helps catch trouble early. Call your doctor right away if you have ongoing nausea, unusual tiredness, belly pain, yellow skin or eyes, dark urine or pale stools.

What side effects are common, and which need a call?

▾
Headache, diarrhea, rash, upset stomach and itching are the common ones, and they are usually mild. Call your doctor for taste or smell changes, low mood, blistering or spreading rash, or signs of infection. Get urgent help for facial swelling or trouble breathing.

Does terbinafine interact with my other medicines?

▾
It can. Terbinafine tablets slow the breakdown of many antidepressants, beta-blockers and some heart rhythm drugs. Rifampin, cimetidine and fluconazole can change terbinafine levels. Show me your full medicine list so we can check.

Is it safe in pregnancy or while breastfeeding?

▾
There isn’t enough human data to judge the risk in pregnancy. Terbinafine does pass into breast milk after oral use. Talk with your doctor to weigh the benefits against the risks.

Is Terbinafine available over the counter?

▾
Both. Some Terbinafine products are sold over the counter and others need a prescription. According to their FDA listings, the topical cream, ointment or gel, topical spray and topical solution forms are sold over the counter and the tablet form needs a prescription. The package says which kind you have. Your pharmacist can tell you which product is right for you.

When was Terbinafine first available?

▾
The earliest FDA record we hold for Terbinafine is from 1992: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when Terbinafine was first used.

Who makes Terbinafine?

▾
41 companies currently list Terbinafine products in the FDA's NDC Directory, including A-S Medication Solutions, Proficient Rx LP, Bryant Ranch Prepack. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →

More about Terbinafine on HelloPharmacist

Detailed data & references for Terbinafine Forms & strengths, pricing, billing codes, manufacturers, safety reports and sourcing — the data behind the page. Most people can stop here. Each section below opens on a tap.

Terbinafine forms and strengths (how it comes)

Terbinafine is available in 4 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Terbinafine inactive ingredients by manufacturer.

Tablet

By mouth
How this form is used
What it may be used for
  • Terbinafine tablets treat fungal infection of the toenail or fingernail due to dermatophytes (onychomycosis).
  • Terbinafine tablets require lab confirmation of the nail infection before starting.
Important instructions
  • Terbinafine tablets are taken once daily, with or without food.
  • Terbinafine tablets are used for a shorter course for fingernails than for toenails.
  • Terbinafine tablets call for a liver check before starting.
Available strengths 3 strengths
83 FDA-listed product records ⓘ

Topical cream, ointment or gel

On the skin
Brands Antifungal Athlete Foot Cream Athletes Foot Cvs CVS Pharmacy Good Neighbor Pharmacy Lamisil AT Cream Lamisil At Terbinafine Hydrochloride Silka Walgreens
How this form is used
What it may be used for
  • Athletes Foot, Curist, Antifungal and Athlete Foot Cream products cure most athlete’s foot, jock itch and ringworm.
  • Cvs cream is labeled for jock itch and for relieving itching, burning, cracking and scaling.
Important instructions
  • Athletes Foot and Curist creams are for adults and children 12 and older. Ask a doctor for children under 12.
  • Athletes Foot cream is applied to clean, dry skin. Use it twice daily for athlete’s foot and once daily for jock itch and ringworm.
  • Athletes Foot cream users should wash their hands after each use.
Available strengths 1 strength
57 FDA-listed product records ⓘ

Topical spray

On the skin
Brands Lamisil AT
How this form is used
What it may be used for
  • Lamisil AT spray cures most athlete’s foot between the toes, jock itch and ringworm.
  • Lamisil AT spray relieves itching, burning, cracking and scaling.
Important instructions
  • Lamisil AT spray is for adults and children 12 and older. Ask a doctor for children under 12.
  • Lamisil AT spray goes on clean, dry skin, held 4 to 6 inches away.
  • Lamisil AT spray is used twice daily for athlete’s foot and once daily for jock itch and ringworm.
Available strengths 1 strength
2 FDA-listed product records ⓘ

Topical solution

On the skin
Brands Toenail Fungus Treatment
How this form is used
What it may be used for
  • Toenail Fungus Treatment liquid is for nail fungus, discoloration, thickening, splitting, crumbling and brittleness.
Available strengths 1 strength
1 FDA-listed product record ⓘ

Terbinafine on the U.S. market: products, makers and brands

How Terbinafine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

41 companies list 75 Terbinafine product records with the FDA, mostly as tablet, topical cream, ointment or gel, topical spray; the earliest marketing or approval year on record is 1992. Brand names on the directory include Lamisil, Silka Cream, Athletes Foot and 13 more; the rest are generics.

4
Dose forms ⓘ
41
Labelers (makers, repackagers, distributors)
23
Brand names
75
FDA-listed product records ⓘ
1992
Earliest FDA record ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (27) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

A-S Medication Solutions8%
Proficient Rx LP8%
Bryant Ranch Prepack7%
Karo Healthcare Inc.7%
NuCare Pharmaceuticals,Inc.5%
Remedyrepack Inc.5%
Other makers60%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How widely Terbinafine is used (Medicaid data)

A general measure of how commonly Terbinafine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Terbinafine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

478,667
Medicaid prescriptions filled (Q1–Q4 2025)
$6.4M gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Terbinafine prescribed? Of the 1,601 medications we measure, Terbinafine ranks #269 by Medicaid prescriptions — more than 83% of them.

Where Terbinafine ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Terbinafine product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 250 mg oral tablet is the most-dispensed Terbinafine product — about 85% of these Medicaid prescriptions.

terbinafine 250 MG Oral Tablet Most dispensed

407,419 Medicaid prescriptions (Q1–Q4 2025) 85% of Terbinafine prescriptions shown $5.2M gross reimbursement (before rebates) ≈ $13 per prescription (gross)

Summed across the 9 of 194 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 313222

terbinafine hydrochloride 10 MG/ML Topical Cream

71,248 Medicaid prescriptions (Q1–Q4 2025) 15% of Terbinafine prescriptions shown $1.2M gross reimbursement (before rebates) ≈ $16 per prescription (gross)

Summed across the 6 of 63 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 992528

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Terbinafine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 15 of 257 listed Terbinafine NDCs with Medicaid activity.

Compare Terbinafine products

A representative set of FDA-listed product records for Terbinafine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 75 of 75 products — FDA National Drug Code Directory. See every product, package size and price: browse all 75 Terbinafine NDCs →

Terbinafine recall history

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Terbinafine recalls since July 2021.

✅No Terbinafine recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.

Ingredient (IN) Terbinafine RxCUI 37801 5 dose forms · 5 strengths
  1. Dose form (SCDF) Oral Tablet RxCUI 374036 In current FDA listings
    Clinical drug / strength (SCD) 250 MG RxCUI 313222
  2. Dose form (SCDF) Topical Cream RxCUI 377935 In current FDA listings
    Clinical drug / strength (SCD) hydrochloride 10 MG/ML RxCUI 992528
  3. Dose form (SCDF) Topical Gel RxCUI 451963 In current FDA listings
    Clinical drug / strength (SCD) 0.01 MG/MG RxCUI 415685
  4. Dose form (SCDF) Topical Solution RxCUI 374035 In current FDA listings
    Clinical drug / strength (SCD) hydrochloride 10 MG/ML RxCUI 992531
  5. Dose form (SCDF) Topical Spray RxCUI 385102 In current FDA listings
    Clinical drug / strength (SCD) hydrochloride 10 MG/ML RxCUI 992535

Look up RxCUI 37801 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

💵 What Terbinafine costs pharmacies (NADAC benchmark)

The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.

FormStrengthPharmacy acquisition benchmark
Tablet · Oral 250 mg $0.143 per tablet NDC details & price history
Tablet · Oral 250 1-Jan $0.143 per tablet NDC details & price history
Why show this? Your out-of-pocket cost depends on insurance, pharmacy markup, and discounts — but the acquisition benchmark tells you whether the medication itself is inexpensive or costly, which strengths cost more per dose, and whether a cash-price quote is in a reasonable range. Each row links to the NDC-level record with its full price history.

Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.

Terbinafine brand names

Terbinafine is sold under 16 brand names in the FDA directory — Lamisil, Silka Cream, Athletes Foot, Lamisil AT Cream and others. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.

Lamisil Silka Cream Athletes Foot Lamisil AT Cream Good Neighbor Pharmacy Antifungal Silka Athlete Foot Cream Lamisil AT Cvs CVS Pharmacy Toenail Fungus Treatment Walgreens Curist Antifungal Relief Lamisil At Terbinafine Hydrochloride CVS Pharmacy Athletes Foot

Who makes Terbinafine: manufacturers and labelers

41 companies list Terbinafine products with the FDA. By number of product records, the largest are A-S Medication Solutions, Proficient Rx LP, Bryant Ranch Prepack. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

A-S Medication Solutions 6 Proficient Rx LP 6 Bryant Ranch Prepack 5 Karo Healthcare Inc. 5 NuCare Pharmaceuticals,Inc. 4 Remedyrepack Inc. 4 Preferred Pharmaceuticals Inc. 3 CVS Pharmacy 2 Cipla USA Inc. 2 Genomma Lab USA, Inc. 2 Golden State Medical Supply, Inc. 2 PD-Rx Pharmaceuticals, Inc. 2 Sun Pharmaceutical Industries, Inc. 2 Voyant Beauty Inc. 2 Walgreen Company 2 American Health Packaging 1 AmerisourceBergen 1 Amerisyn LLC 1 Amici Pharma, Inc. 1 Aphena Pharma Solutions - Tennessee, LLC 1 Aurobindo Pharma Limited 1 Beautivity LLC 1 Bionpharma Inc. 1 Breckenridge Pharmaceutical, Inc. 1

…and 17 more on the FDA NDC directory.

Terbinafine drug class (RxNorm)

Terbinafine belongs to the Allylamine Antifungal class.

Pharmacologic class Allylamine Antifungal
Drug family (ATC) Other antifungals for topical use, Antifungals for systemic use

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

Sources for this Terbinafine page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Oct 29, 2020
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Terbinafine.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Terbinafine after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
48
Finished products in the current FDA directory
75
Companies listing them (makers, repackagers, distributors)
41
FDA labeler codes behind them ⓘ
46
Linked representative label ⓘ
Exelan Pharmaceuticals Inc.
Linked label effective
Oct 29, 2020
Composite sections available
24
Linked SPL Set ID
6dc279cc-9861-4fa8-8083-ca3b3c57b513
Linked SPL Document ID
dc86cdd6-0a8a-4e5c-b3c4-8b05388af862
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Exelan Pharmaceuticals Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →